|
Nathan D. Waal ( San Francisco, CA )
|
|
|
Nathan D. Waal ( San Francisco, CA )
|
Compounds of formulae I and I', methods of making them, pharmaceutical compositions containing them, and methods for their use. The compounds are antagonists of IL-2/IL-2R binding; and are useful for the treatment of interleukin-2 mediated diseases, such as autoimmune diseases (such as rheumatoid arthritis, multiple sclerosis, uveitis, and psoriasis), allograft rejection, and graft-versus-host disease.
Triphenyl compounds of the formulae I, II, and VI: ##STR1## methods of making them, pharmaceutical compositions containing them, and methods for their use. The compounds are compounds are interleukin-4 antagonists; and are useful for the treatment of asthma and allergies.
|
|
|